Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kert Viele

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Statistics in Medicine|April 24, 2023
Allocation in platform trials to maintain comparability across time and eligibilityKert Viele
JAMA|December 2, 2015
Dose-Finding Trials: Optimizing Phase 2 Data in the Drug Development ProcessKert Viele, Jason T Connor
JAMA|June 20, 2023
Revisiting the Analogy Between Clinical Trials and Diagnostic Tests by Interpreting a Negative Trial as a Negative Test for EfficacyRoger J Lewis, Kert Viele
American Journal of Respiratory and Critical Care Medicine|October 19, 2020
Risk, Results, and Costs: Optimizing Clinical Trial Efficiency through Prognostic EnrichmentKert Viele, Timothy D Girard
JAMA|December 12, 2018
Bayesian Hierarchical ModelsAnna E McGlothlin, Kert Viele
JAMA|April 20, 2016
Interpretation of Clinical Trials That Stopped EarlyKert Viele, Anna McGlothlin, Kristine Broglio
JAMA|October 26, 2017
Bayesian Analysis: Using Prior Information to Interpret the Results of Clinical TrialsMelanie Quintana, Kert Viele, Roger J Lewis
JAMA|March 5, 2026
The Hochberg Procedure for the Comparison of Multiple End PointsJessica R Overbey, Barbara Wendelberger, Kert Viele
Synapse (New York, N.Y.)|April 1, 2006
Self-modeling structure of evoked postsynaptic potentialsKert Viele, Mark Lancaster, Robin L Cooper
Journal of Cardiac Failure|October 5, 2024
COUNTERPOINT: Abandon or Reassess? Interpreting Treatment Effects in "Negative" Clinical TrialsJessica R Overbey, Shelley Zieroth, Kert Viele
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Statistics in Medicine|April 24, 2023
Allocation in platform trials to maintain comparability across time and eligibilityKert Viele
JAMA|December 2, 2015
Dose-Finding Trials: Optimizing Phase 2 Data in the Drug Development ProcessKert Viele, Jason T Connor
JAMA|June 20, 2023
Revisiting the Analogy Between Clinical Trials and Diagnostic Tests by Interpreting a Negative Trial as a Negative Test for EfficacyRoger J Lewis, Kert Viele
American Journal of Respiratory and Critical Care Medicine|October 19, 2020
Risk, Results, and Costs: Optimizing Clinical Trial Efficiency through Prognostic EnrichmentKert Viele, Timothy D Girard
JAMA|December 12, 2018
Bayesian Hierarchical ModelsAnna E McGlothlin, Kert Viele
JAMA|April 20, 2016
Interpretation of Clinical Trials That Stopped EarlyKert Viele, Anna McGlothlin, Kristine Broglio
JAMA|October 26, 2017
Bayesian Analysis: Using Prior Information to Interpret the Results of Clinical TrialsMelanie Quintana, Kert Viele, Roger J Lewis
JAMA|March 5, 2026
The Hochberg Procedure for the Comparison of Multiple End PointsJessica R Overbey, Barbara Wendelberger, Kert Viele
Synapse (New York, N.Y.)|April 1, 2006
Self-modeling structure of evoked postsynaptic potentialsKert Viele, Mark Lancaster, Robin L Cooper
Journal of Cardiac Failure|October 5, 2024
COUNTERPOINT: Abandon or Reassess? Interpreting Treatment Effects in "Negative" Clinical TrialsJessica R Overbey, Shelley Zieroth, Kert Viele
Pageof 6